secwatch.observer — SEC 8-K summary
======================================

Issuer:     MARIMED INC. (MRMD)
CIK:        0001522767
Form:       8-K
Filed at:   2022-04-14T23:59:59+00:00
Accession:  0001493152-22-009916
Event type: m_and_a
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MariMed gets Maryland approval to acquire Kind Therapeutics; over 139K patients in state program
--------------------------------------------------------------------------------

- MMCC approved transfer of 100% ownership of Kind Therapeutics to MariMed on April 13, 2022.
- Kind operates a cultivation/production facility in Hagerstown, MD and is developing a dispensary in Anne Arundel County.
- Maryland's medical cannabis program has over 139,000 patients and generated $500M+ in sales in 2021.
- Upon closing, Kind will become a wholly owned subsidiary, consolidating its financials with MariMed.
- MariMed (OTCQX: MRMD) expects to close the previously announced acquisition following this approval.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1522767/000149315222009916/0001493152-22-009916-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1522767/000149315222009916/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-009916

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer